The Lee Kong Chian School of Medicine (LKCMedicine) trains doctors who put patients at the centre of their exemplary care. The School, which offers both undergraduate and graduate programmes, is named after local philanthropist Tan Sri Dato Lee Kong Chian. Established in 2010 by Nanyang Technological University, Singapore, in partnership with Imperial College London, LKCMedicine aims to be a model for innovative medical education and a centre for transformative research. The School’s primary clinical partner is the National Healthcare Group, a leader in public healthcare recognised for the quality of its medical expertise, facilities and teaching. The School is transitioning to an NTU medical school ahead of the 2028 successful conclusion of the NTU-Imperial partnership to set up a Joint Medical School. In August 2024, we welcomed our first intake of the NTU MBBS programme, that has been recently enhanced to include themes like precision medicine and Artificial Intelligence (AI) in healthcare, with an expanded scope in the medical humanities. Graduates from the five-year undergraduate medical degree programme will have a strong understanding of the scientific basis of medicine, with an emphasis on technology, data science and the humanities.
A Research Assistant position is available to join the Microbiome Medicine Laboratory at A/Prof Sunny Wong's lab at the Lee Kong Chian School of Medicine, Nanyang Technological University (NTU).
We are seeking individuals with a passion for molecular microbiology to join our team and contribute to our ongoing research initiatives focused on the human microbiome. Our research efforts are primarily in studying cancer, bacterial culture, the interactions between microorganisms, their hosts and the environment. Our ultimate goal is to develop a comprehensive understanding of how these processes influence microbial communities and impact the health of the host by utilizing cellular and animal models.
By facilitating both clinical and laboratory research, the Research Assistant will directly contribute to the laboratory’s efforts in uncovering key insights into the role of the microbiome in systemic diseases, ultimately driving groundbreaking discoveries that align with the University’s commitment to improving health outcomes through innovative science.